Eledon Pharmaceuticals Income Statement (2013-2026) | ELDN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Cost of Revenue (Quarter)												1.30M	1.33M	4.25M	4.62M	1.67M	2.01M	1.88M	9.46M	7.79M
Operating items
Research & Development (Quarter)	4.24M	7.66M	6.18M	6.63M	5.74M	7.45M	7.25M	8.11M	7.20M	7.93M	7.07M	7.41M	10.11M	16.52M	17.93M	13.53M	20.28M	14.97M		17.20M
Selling, General & Administrative (Quarter)	3.73M	2.85M	3.20M	3.22M	3.54M	3.15M	2.79M	3.00M	3.15M	3.27M	3.27M	3.46M	4.40M	3.99M	6.77M	4.43M	4.46M	4.10M		3.98M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)							48.65M								-64.03M				-54.29M
Operating Expenses (Quarter)	7.97M	10.51M	9.38M	9.86M	9.28M	10.60M	58.69M	11.11M	10.35M	11.20M	10.34M	10.87M	14.50M	20.51M	-39.34M	17.96M	24.73M	19.07M	-54.29M	21.18M
Operating Income (Quarter)	-7.97M	-10.51M	19.74M	-9.86M	-9.28M	-10.60M	11.27M	-11.11M	-10.35M	-11.20M	8.19M	-10.87M	-14.50M	-20.51M	38.37M	-17.96M	-24.73M	-19.07M		-21.18M
EBIT (Quarter)	-7.97M	-10.51M	19.74M	-9.86M	-9.28M	-10.60M	11.27M	-11.11M	-10.35M	-11.20M	8.19M	-10.87M	-14.50M	-20.51M	38.37M	-17.96M	-24.73M	-19.07M		-21.18M
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)	-0.00M	0.00M		-0.01M	0.04M	0.13M	0.30M	0.34M	0.78M	0.85M	0.71M	0.57M	0.87M	1.04M	1.44M	1.41M	1.22M	1.05M		1.12M
Non Operating Income (Quarter)	-0.00M	0.00M		-0.01M	0.04M	0.13M	0.30M	0.34M	0.78M	0.85M	0.71M	0.57M	0.87M	1.04M	1.44M	1.41M	1.22M	1.05M		1.12M
Net income details
EBT (Quarter)	-7.97M	-10.50M	27.67M	-9.86M	-9.25M	-10.47M	-58.38M	-11.11M	-10.35M	-11.20M	8.19M	-10.87M	-14.50M	-20.51M	38.37M	-17.96M	-24.73M	-19.07M		-21.18M
Tax Provisions (Quarter)	-0.59M	-0.69M	-0.58M
Profit After Tax (Quarter)	-7.38M	-9.82M	-8.81M	-9.86M	-9.25M	-10.47M	-58.38M	-10.77M	-65.76M	-9.91M	-30.10M	-23.63M	-44.91M	76.97M	-44.62M	-6.50M	-11.22M	-17.46M	-10.42M	-39.02M
Income from Continuing Operations (Quarter)	-7.38M	-9.82M	28.25M	-9.86M	-9.25M	-10.47M	-58.38M	-11.11M	-10.35M	-11.20M	8.19M	-10.87M	-14.50M	-20.51M	38.37M	-17.96M	-24.73M	-19.07M		-21.18M
Consolidated Net Income (Quarter)	-7.38M	-9.82M	28.25M	-9.86M	-9.25M	-10.47M	-58.38M	-11.11M	-10.35M	-11.20M	8.19M	-10.87M	-14.50M	-20.51M	38.37M	-17.96M	-24.73M	-19.07M		-21.18M
Income towards Parent Company (Quarter)	-7.38M	-9.82M	28.25M	-9.86M	-9.25M	-10.47M	-58.38M	-11.11M	-10.35M	-11.20M	8.19M	-10.87M	-14.50M	-20.51M	38.37M	-17.96M	-24.73M	-19.07M		-21.18M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-7.38M	-9.82M	28.25M	-9.86M	-9.25M	-10.47M	-58.38M	-11.11M	-10.35M	-11.20M	8.19M	-19.50M	-39.03M	-15.70M	21.24M	-6.00M	-10.36M	-16.13M	-9.84M	-36.94M
Additional items
EPS (Basic) (Quarter)	-0.50	-0.66	-0.60	-0.69	-0.65	-0.73	-4.09	-0.75	-2.74	-0.33	0.05	-36.12	-1.06	1.05	-0.79	-0.08	-0.13	-0.21	-0.19	-0.33
EPS (Weighted Average and Diluted) (Quarter)	-0.50	-0.66	-0.60	-0.69	-0.65	-0.73	-4.09	-0.75	-2.74	-0.33	-0.94	-0.65	-51.29	-0.28	0.48	-0.08	-0.13	-0.21	-0.12	-0.33
Shares Outstanding (Weighted Average) (Quarter)	14.82M	14.82M	14.82M	14.33M	14.27M	14.27M	14.29M	14.29M	24.01M	29.97M	21.56M	29.99M	42.28M	51.95M	48.54M	77.13M	77.16M	77.16M	51.78M	112.42M
Shares Outstanding (Diluted Average) (Quarter)	14.82M	14.82M	14.82M	14.33M	14.27M	14.29M	14.29M	14.29M	24.01M	22.81M	0.12M	0.11M	0.11M	55.48M	48.54M	77.13M	77.16M	77.16M	81.84M	112.42M
EBITDA (Quarter)	-7.97M	-10.51M	19.74M	-9.86M	-9.28M	-10.60M	11.27M	-11.11M	-10.35M	-9.91M	8.19M	-10.87M	-14.50M	77.07M	-44.72M	-17.96M	-24.73M	-19.07M		-21.18M
Tax Rate (Quarter)	7.38%	6.53%	-2.09%

Research Tools

Eledon Pharmaceuticals Income Statement (2013-2026) | ELDN

Create an account

Sign In

Reset Password